{"component": "definition", "props": {"groups": [{"snippet": "has the meaning set forth in Section 3.5.", "snippet_links": [{"key": "section-35", "type": "clause", "offset": [29, 40]}], "size": 10, "samples": [{"hash": "1DcXDOYaMK9", "uri": "/contracts/1DcXDOYaMK9#permitted-subcontractors", "label": "Collaboration Agreement (Macrogenics Inc)", "score": 24.7563312799, "published": true}, {"hash": "kDZYo4wEeh4", "uri": "/contracts/kDZYo4wEeh4#permitted-subcontractors", "label": "Collaboration Agreement (Macrogenics Inc)", "score": 24.6741957563, "published": true}, {"hash": "1NLdooRbXR", "uri": "/contracts/1NLdooRbXR#permitted-subcontractors", "label": "Collaboration Agreement (Macrogenics Inc)", "score": 24.5838466804, "published": true}], "hash": "d96e1af961bb611d9ba7734312e69c3f", "id": 1}, {"snippet": "means subcontractors that Administrator uses to provide the Services.", "snippet_links": [{"key": "the-services", "type": "definition", "offset": [56, 68]}], "size": 3, "samples": [{"hash": "4LSerI79HX6", "uri": "/contracts/4LSerI79HX6#permitted-subcontractors", "label": "Master Services Agreement (Variable Account I of AGL of Delaware)", "score": 21.0034223135, "published": true}, {"hash": "6lPllMhNhkH", "uri": "/contracts/6lPllMhNhkH#permitted-subcontractors", "label": "Master Services Agreement (Variable Account I of AGL of Delaware)", "score": 20.3271731691, "published": true}], "hash": "ddc94b1bcaf63f8488f0cc960ce3ea19", "id": 2}, {"snippet": "is defined in Section 14.4 (Subcontracting).", "snippet_links": [{"key": "section-144", "type": "clause", "offset": [14, 26]}], "size": 2, "samples": [{"hash": "hXQ94o6SEx3", "uri": "/contracts/hXQ94o6SEx3#permitted-subcontractors", "label": "Collaboration and License Agreement (Nurix Therapeutics, Inc.)", "score": 35.12183436, "published": true}, {"hash": "6Z7t0EGlnra", "uri": "/contracts/6Z7t0EGlnra#permitted-subcontractors", "label": "Collaboration and License Agreement (Nurix Therapeutics, Inc.)", "score": 34.7768651608, "published": true}], "hash": "694e6f3283dc8c3992566a875977af43", "id": 3}, {"snippet": "means Odebrecht \u00d3leo e G\u00e1s S.A., Odebrecht Oil Services Ltd., Teekay Petrojarl Production AS;", "snippet_links": [], "size": 2, "samples": [{"hash": "4fRv7Uc8azP", "uri": "https://www.sec.gov/Archives/edgar/data/911971/000119312516556541/d127018dex427.htm", "label": "Credit Agreement (Teekay Corp)", "score": 15.3162217659, "published": false}, {"hash": "iyX0xfNw9TG", "uri": "https://www.sec.gov/Archives/edgar/data/1382298/000119312515293181/d87549dex24.htm", "label": "Credit Agreement (Teekay Offshore Partners L.P.)", "score": 14.6235455168, "published": false}], "hash": "e3b9374e79b5b3f83c0c99d653e9eddc", "id": 4}, {"snippet": "has the meaning as set forth in Section 4.3.6.", "snippet_links": [], "size": 2, "samples": [{"hash": "1TjdfIzmkrb", "uri": "/contracts/1TjdfIzmkrb#permitted-subcontractors", "label": "Global Supply Agreement (Horizon Pharma PLC)", "score": 26.7399041752, "published": true}, {"hash": "6BYH0wWSDEG", "uri": "/contracts/6BYH0wWSDEG#permitted-subcontractors", "label": "Global Supply Agreement (Horizon Pharma PLC)", "score": 26.5975359343, "published": true}], "hash": "6ac7da5a74baef7a4c6da20416fa8ab5", "id": 5}, {"snippet": "means (i) Georgetown University, and (ii) additional Third Party subcontractors hired by SHUTTLE to perform work related to the Cell-Based Models for Prostate Cancer. All Permitted Subcontractors other than Georgetown University will require a sublicense from PROPAGENIX, with terms to be negotiated in good faith between the Parties.", "snippet_links": [{"key": "third-party-subcontractors", "type": "clause", "offset": [53, 79]}, {"key": "related-to", "type": "clause", "offset": [113, 123]}, {"key": "prostate-cancer", "type": "clause", "offset": [150, 165]}, {"key": "terms-to-be-negotiated", "type": "clause", "offset": [277, 299]}, {"key": "in-good-faith", "type": "clause", "offset": [300, 313]}, {"key": "between-the-parties", "type": "clause", "offset": [314, 333]}], "size": 1, "samples": [{"hash": "6gYaHk8PSGU", "uri": "/contracts/6gYaHk8PSGU#permitted-subcontractors", "label": "Sublicense Agreement (Shuttle Pharmaceuticals Holdings, Inc.)", "score": 33.4736481862, "published": true}], "hash": "f03aad22b15e0d04eb24ed96a435858c", "id": 6}, {"snippet": "means the Third Party contractors listed on Schedule 1.137 that have been preapproved by Merck to work on behalf of C4T to perform certain activities under this Agreement. 1.138 \u201cPerson\u201d means any individual, partnership, joint venture, limited liability company, corporation, firm, trust, association, unincorporated organization, governmental authority or agency, or any other entity not specifically listed herein. 1.139 \u201cPhase I Clinical Trial\u201d means a human clinical trial in any country that would satisfy the requirements of 21 CFR 312.21(a) or similar requirements under Applicable Law in such country. 1.140 \u201cPhase II Clinical Trial\u201d means a human clinical trial in any country that would satisfy the requirements of 21 CFR 312.21(b) or similar requirements under Applicable Law in such country. 1.141 \u201cPhase III Clinical Trial\u201d means a human clinical trial in any country that would satisfy the requirements of 21 CFR 312.21(c) or similar requirements under Applicable Law in such country.", "snippet_links": [{"key": "third-party-contractors", "type": "definition", "offset": [10, 33]}, {"key": "on-schedule", "type": "definition", "offset": [41, 52]}, {"key": "by-merck", "type": "clause", "offset": [86, 94]}, {"key": "on-behalf-of", "type": "clause", "offset": [103, 115]}, {"key": "activities-under-this-agreement", "type": "clause", "offset": [139, 170]}, {"key": "joint-venture", "type": "clause", "offset": [222, 235]}, {"key": "limited-liability-company", "type": "definition", "offset": [237, 262]}, {"key": "governmental-authority", "type": "definition", "offset": [332, 354]}, {"key": "other-entity", "type": "clause", "offset": [373, 385]}, {"key": "phase-i-clinical-trial", "type": "definition", "offset": [425, 447]}, {"key": "human-clinical-trial", "type": "definition", "offset": [457, 477]}, {"key": "the-requirements", "type": "clause", "offset": [512, 528]}, {"key": "applicable-law", "type": "definition", "offset": [579, 593]}, {"key": "phase-ii-clinical-trial", "type": "definition", "offset": [618, 641]}, {"key": "phase-iii-clinical-trial", "type": "definition", "offset": [812, 836]}], "size": 1, "samples": [{"hash": "keLi1TxweZy", "uri": "/contracts/keLi1TxweZy#permitted-subcontractors", "label": "License and Collaboration Agreement (C4 Therapeutics, Inc.)", "score": 33.1409993155, "published": true}], "hash": "bd2daa516873e817f910bc0edb38f96c", "id": 7}, {"snippet": "means the Third Party contractors listed on Error! Reference source not found. or in the Work Plan that have otherwise been preapproved by MKDG to work on behalf of C4T to perform certain activities under this Agreement. 1.82 \u201cPerson\u201d means any individual, corporation, company, partnership, association, joint-stock company, trust, unincorporated organization or government or political subdivision thereof. 1.83 \u201cPhase I Clinical Trial\u201d means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate", "snippet_links": [{"key": "third-party-contractors", "type": "definition", "offset": [10, 33]}, {"key": "reference-source", "type": "definition", "offset": [51, 67]}, {"key": "the-work-plan", "type": "clause", "offset": [85, 98]}, {"key": "on-behalf-of", "type": "clause", "offset": [152, 164]}, {"key": "activities-under-this-agreement", "type": "clause", "offset": [188, 219]}, {"key": "stock-company", "type": "definition", "offset": [311, 324]}, {"key": "political-subdivision", "type": "definition", "offset": [378, 399]}, {"key": "phase-i-clinical-trial", "type": "definition", "offset": [415, 437]}, {"key": "to-generate", "type": "definition", "offset": [574, 585]}], "size": 1, "samples": [{"hash": "8qvwIxuryVQ", "uri": "/contracts/8qvwIxuryVQ#permitted-subcontractors", "label": "Research Collaboration and License Agreement (C4 Therapeutics, Inc.)", "score": 33.3490759754, "published": true}], "hash": "1f2fb62834a7f5cce96fdb4dd76b42a3", "id": 8}, {"snippet": "means the Third Party subcontractors or vendors specified in the Quality Agreement, or in the case of Services, as specified in the applicable SOW.", "snippet_links": [{"key": "third-party-subcontractors", "type": "clause", "offset": [10, 36]}, {"key": "quality-agreement", "type": "clause", "offset": [65, 82]}, {"key": "in-the-case", "type": "clause", "offset": [87, 98]}, {"key": "as-specified", "type": "clause", "offset": [112, 124]}, {"key": "the-applicable", "type": "clause", "offset": [128, 142]}], "size": 1, "samples": [{"hash": "fwYzGXTQ4qk", "uri": "/contracts/fwYzGXTQ4qk#permitted-subcontractors", "label": "Manufacturing and Supply Agreement (Homology Medicines, Inc.)", "score": 33.2217659138, "published": true}], "hash": "2e333288c9f252494b65391de3531aaa", "id": 9}, {"snippet": "means subcontractors (including Affiliates of Provider) approved by Company used to provide the Services in accordance with and pursuant to Article 17. \u201cPersonal Data\u201d shall mean (a) any information provided to or collected by Provider (i) that identifies or can be used to identify, contact, locate, or be traced back to the specific person to whom such information pertains, or when used in combination with other information provided hereunder or Processed by Provider on behalf of any of the Company Entities, identifies an individual; or (ii) from which identification or contact information of an individual person can be derived; (b) Sensitive Personal Data; and (c) protected health information. Personal Data can be in any media or format, including computerized or electronic records as well as paper-based files. Personal Data may include: (i) a first or last name or initials; (ii) a home or other physical address, including street name and name of city or town; (iii) an email address or other online contact information, such as an instant messaging user identifier or a screen name that reveals an individual\u2019s email address; (iv) a telephone number; (v) a social security number , tax ID number or other government-issued identifier; (vi) an Internet Protocol (\u201cIP\u201d) address or host name that identifies an individual; (vii) a persistent identifier, such as a customer number held in a \u201ccookie\u201d or processor serial number, that is combined with other available data that identifies an individual; (viii) birth dates or treatment dates; (ix) coded data that is derived from Personal Data;", "snippet_links": [{"key": "by-company", "type": "clause", "offset": [65, 75]}, {"key": "the-services", "type": "definition", "offset": [92, 104]}, {"key": "in-accordance-with", "type": "definition", "offset": [105, 123]}, {"key": "article-17", "type": "definition", "offset": [140, 150]}, {"key": "information-provided", "type": "clause", "offset": [187, 207]}, {"key": "by-provider", "type": "clause", "offset": [224, 235]}, {"key": "specific-person", "type": "definition", "offset": [326, 341]}, {"key": "such-information", "type": "definition", "offset": [350, 366]}, {"key": "in-combination", "type": "definition", "offset": [390, 404]}, {"key": "other-information", "type": "definition", "offset": [410, 427]}, {"key": "on-behalf-of", "type": "clause", "offset": [472, 484]}, {"key": "company-entities", "type": "clause", "offset": [496, 512]}, {"key": "an-individual", "type": "clause", "offset": [525, 538]}, {"key": "information-of", "type": "clause", "offset": [585, 599]}, {"key": "individual-person", "type": "clause", "offset": [603, 620]}, {"key": "sensitive-personal-data", "type": "clause", "offset": [641, 664]}, {"key": "protected-health-information", "type": "definition", "offset": [674, 702]}, {"key": "electronic-records", "type": "clause", "offset": [775, 793]}, {"key": "physical-address", "type": "clause", "offset": [910, 926]}, {"key": "street-name", "type": "definition", "offset": [938, 949]}, {"key": "city-or-town", "type": "definition", "offset": [962, 974]}, {"key": "email-address", "type": "definition", "offset": [985, 998]}, {"key": "online-contact-information", "type": "definition", "offset": [1008, 1034]}, {"key": "instant-messaging", "type": "definition", "offset": [1047, 1064]}, {"key": "telephone-number", "type": "clause", "offset": [1149, 1165]}, {"key": "social-security-number", "type": "definition", "offset": [1173, 1195]}, {"key": "internet-protocol", "type": "definition", "offset": [1259, 1276]}, {"key": "customer-number", "type": "definition", "offset": [1377, 1392]}, {"key": "serial-number", "type": "clause", "offset": [1425, 1438]}, {"key": "available-data", "type": "clause", "offset": [1468, 1482]}, {"key": "coded-data", "type": "definition", "offset": [1558, 1568]}], "size": 1, "samples": [{"hash": "fyoVpxdAp3p", "uri": "/contracts/fyoVpxdAp3p#permitted-subcontractors", "label": "Master Services Agreement (Spark Networks SE)", "score": 32.7029431896, "published": true}], "hash": "d1d8f4ea9f95ed8858cd48c2312c4526", "id": 10}], "next_curs": "CmUSX2oVc35sYXdpbnNpZGVyY29udHJhY3RzckELEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIhcGVybWl0dGVkLXN1YmNvbnRyYWN0b3JzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "has the meaning set forth in Section 3.5.", "size": 29, "title": "Permitted Subcontractors", "id": "permitted-subcontractors", "examples": ["LICENSEE will, and will require its SUBLICENSEES and <strong>Permitted Subcontractors</strong> to, indemnify, hold harmless, and defend REGENTS and its officers, employees, and agents; sponsor(s) of the research that led to the INVENTION; and the inventors of any patents and patent applications under REGENTS\u2019 PATENT RIGHTS and their employers against any and all claims, suits, losses, damages, costs, fees, and expenses resulting from or arising out of exercise of this AGREEMENT or any SUBLICENSE.", "<strong>Permitted Subcontractors</strong> who will perform Restricted Activities as of the Effective Date are listed in Exhibit 4.", "Customer consents to such listed <strong>Permitted Subcontractors</strong> performing the Restricted Activities.", "CDS and/or its <strong>Permitted Subcontractors</strong> shall use Commercially Reasonable Efforts to provide an adequate and timely clinical supply, but limited to such quantities and such type and specification as set forth in Section 3.1.2 and all in accordance with GMP and/or ISO standards, to the extent applicable for clinical trials in the relevant country, and other applicable laws and regulations.", "The Recipient shall notify the Disclosing Party of any breach by Recipient or Recipient\u2019s Affiliates, Representatives and any <strong>Permitted Subcontractors</strong> of the obligations under this Section 6.2 as soon as practicable upon becoming aware of such breach.", "It is recognized by the Parties that Impax and/or its <strong>Permitted Subcontractors</strong> may from time to time receive orders for the Product directly from Third Parties.", "Without limiting Wyeth\u2019s ability to withhold approval for other valid reason, any such agreement or any amendment or modification thereto shall provide for such Permitted Subcontractor to fulfill the obligations imposed under this Agreement on Impax and/or its <strong>Permitted Subcontractors</strong> and shall name Wyeth as a Third Party beneficiary with direct enforcement rights against the Permitted Subcontractor.", "Impax shall take all steps necessary to ensure that its Permitted Subcontractor(s), each member of the Impax Sales Force and all other Impax Personnel comply with the requirements of the PDMA, all regulations promulgated thereunder, and each State\u2019s companion PDMA statutes and regulations which relate to the distribution of samples of a prescription drug product utilizing the Sample Carry Program set forth below in Sections 10.4.", "Impax and Impax\u2019s Permitted Subcontractor(s) shall implement the following program for samples (\u201cSample Carry Program\u201d) that includes the following elements and shall operate such program in accordance with Applicable Law and regulations and its company standard operating procedures for product sampling.", "Additionally, Impax, at its own expense, shall provide each member of the Impax Sales Force with email and voicemail access for use by Impax, each of its <strong>Permitted Subcontractors</strong> and Wyeth in communicating with the Impax Sales Force, as the same may be communicated to Impax by Wyeth in writing from time to time."], "related": [["subcontractors", "Subcontractors", "Subcontractors"], ["contractors", "Contractors", "Contractors"], ["subcontractor", "Subcontractor", "Subcontractor"], ["sub-contractors", "Sub-Contractors", "Sub-Contractors"], ["sub-subcontractor", "Sub-subcontractor", "Sub-subcontractor"]], "related_snippets": [], "updated": "2025-07-07T00:16:40+00:00"}, "json": true, "cursor": ""}}